What's better than momentum? Mo' momentum.
Let's take a closer look at five of this past week's biggest scorchers.
July 27 Price
|Sarepta Therapeutics (Nasdaq: SRPT )||$8.46||134%||Add|
|InvenSense (NYSE: INVN )||$12.93||32%||Add|
|Nevsun Resources (NYSE: NSU )||$3.74||29%||Add|
|Lumber Liquidators (NYSE: LL )||$44.09||29%||Add|
|Riverbed Technology (Nasdaq: RVBD )||$18.34||20%||Add|
Sarepta Therapeutics was last week's biggest winner, more than doubling on encouraging study results for its experimental muscular dystrophy drug.
Talk about perfect timing! On Monday I singled out InvenSense as one of five stocks under $10 worth buying. A blowout quarterly report two days later pushed the motion-based controller specialist into the double digits. Widening adoption of its Motion Interface offerings by smartphones and tablets finds InvenSense issuing guidance for stronger-than-expected sequential growth in the current quarter.
Gold and copper miner Nevsun Resources struck it rich after announcing increased base-metals reserves at its majority-owned Bisha Mine in Eritrea.
Lumber Liquidators made skeptics walk the plank, posting better-than-expected quarterly results. Net sales rose 20% as the hardwood flooring retailer's stores came through with a 12.4% spike in comps. Earnings more than doubled, blowing past Wall Street's estimates.
Finally, we had Riverbed Technology post encouraging financials. The WAN optimization specialist also posted an encouraging near-term outlook.
More winners for you
It was a great week for these five stocks. If you want to get an early read on some of tomorrow's major gainers, there's a special report on three hidden winners in a booming industry. The report is free -- like this article -- but it won't be around forever, so check it out now.